These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33719152)

  • 1. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
    Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
    J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
    Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
    Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer.
    Guan Q; Yan H; Chen Y; Zheng B; Cai H; He J; Song K; Guo Y; Ao L; Liu H; Zhao W; Wang X; Guo Z
    BMC Genomics; 2018 Jan; 19(1):99. PubMed ID: 29378509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.
    Cheng J; Guo Y; Gao Q; Li H; Yan H; Li M; Cai H; Zheng W; Li X; Jiang W; Guo Z
    Oncotarget; 2017 May; 8(18):30265-30275. PubMed ID: 28427173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative transcriptional signature for the early diagnosis of colorectal cancer.
    Guan Q; Zeng Q; Yan H; Xie J; Cheng J; Ao L; He J; Zhao W; Chen K; Guo Y; Guan G; Guo Z
    Cancer Sci; 2019 Oct; 110(10):3225-3234. PubMed ID: 31335996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust transcriptional signatures for low-input RNA samples based on relative expression orderings.
    Liu H; Li Y; He J; Guan Q; Chen R; Yan H; Zheng W; Song K; Cai H; Guo Y; Wang X; Guo Z
    BMC Genomics; 2017 Nov; 18(1):913. PubMed ID: 29179677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy.
    He J; Cheng J; Guan Q; Yan H; Li Y; Zhao W; Guo Z; Wang X
    Cancer Sci; 2020 Jan; 111(1):253-265. PubMed ID: 31785020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.
    Zhu J; Deane NG; Lewis KB; Padmanabhan C; Washington MK; Ciombor KK; Timmers C; Goldberg RM; Beauchamp RD; Chen X
    Sci Rep; 2016 Sep; 6():33273. PubMed ID: 27623752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.
    Kalmár A; Wichmann B; Galamb O; Spisák S; Tóth K; Leiszter K; Nielsen BS; Barták BK; Tulassay Z; Molnár B
    Diagn Pathol; 2015 Jul; 10():126. PubMed ID: 26208990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
    Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY
    Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients.
    Cai H; Guo W; Zhang S; Li N; Wang X; Liu H; Chen R; Wang S; Guo Z; Li J
    Breast Cancer Res Treat; 2018 Jul; 170(2):271-277. PubMed ID: 29572677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.
    Zhao W; Chen B; Guo X; Wang R; Chang Z; Dong Y; Song K; Wang W; Qi L; Gu Y; Wang C; Yang D; Guo Z
    Oncotarget; 2016 Apr; 7(14):19060-71. PubMed ID: 26967049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
    Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
    Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
    Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
    BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRT17 as a prognostic biomarker for stage II colorectal cancer.
    Ujiie D; Okayama H; Saito K; Ashizawa M; Thar Min AK; Endo E; Kase K; Yamada L; Kikuchi T; Hanayama H; Fujita S; Sakamoto W; Endo H; Saito M; Mimura K; Saze Z; Momma T; Ohki S; Kono K
    Carcinogenesis; 2020 Jul; 41(5):591-599. PubMed ID: 31754689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.